Global Plasma Fractionation Market Set for Rapid Growth, forecasted to Reach New Heights by 2030
According to Intent Market Research, the plasma fractionation market is expected to expand at a compound annual growth rate (CAGR) of 6.4% from USD 27.5 billion in 2023–2030 to USD 42.5 billion by 2030. The main objective of the analysis is to estimate the present market potential for each segment, sub-segment, and region in terms of the total addressable market. All of the emerging and fast-growing technologies were found throughout this procedure, and their effects on the present and future markets were evaluated. The paper additionally delineates the principal stakeholders, their business deficiencies, and their purchasing patterns.
Modern plasma fractionation combines manufacturing steps to isolate, in a sequential and integrated manner, the crude fractions that are further purified into individual therapeutic products. Validated dedicated steps inactivate and/or remove infectious agents potentially present in the starting plasma pool. Plasma is mostly comprised of water, roughly ninety percent of it is water – this is what gives it the straw color. Another 8% is made up of proteins and clotting factors (which are very helpful in medical practice) and the remaining percentages by salts, glucose and lipids circulating in the blood.
Fractionation is a separation process in which a certain quantity of a mixture (of gasses, solids, liquids, enzymes, or isotopes, or a suspension) is divided during a phase transition, into a number of smaller quantities (fractions) in which the composition varies according to a gradient.
Methodology of Plasma Fractionation Market:
Intent Market Research employs a rigorous methodology to minimize residual errors by carefully defining the scope, validating findings through primary research, and consistently updating our in-house database. This dynamic approach allows us to capture ongoing market fluctuations and adapt to evolving market uncertainties.
The research factors used in our methodology vary depending on the specific market being analyzed. To begin with, we incorporate both demand and supply side information into our model to identify and address market gaps. Additionally, we also employ approaches such as Macro-Indicator Analysis, Factor Analysis, Value Chain-Based Sizing, and forecasting to further increase the accuracy of the numbers and validate the findings.
Research Approach
- Secondary Research Approach: In the initial phase of the research process, we continuously record and collect extensive data. This data is carefully filtered and validated against various secondary sources.
- Primary Research Approach: After consolidating the data collected through secondary research, we initiate a validation process to verify all numbers, assumptions and market results through interaction with subject matter experts.
Our market research methodology uses both top-down and bottom-up approaches to segment and estimate quantitative aspects of the market. In addition, we use a multi-perspective analysis in which we look at the market from different perspectives.
Table of Content:
- Market Segmentation
- By Product Type
- Immunoglobulins
- Coagulation Factors
- Albumin
- Protease Inhibitors
- Other Plasma Products
- By Application
- Neurology
- Hematology
- Immunology
- Critical Care
- Pulmonology
- Other Applications
- By End User
- Hospitals and Clinics
- Academic and Research Institutes
- Clinical Research Laboratories
- Regional Analysis
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
